Tricuspid Aortic Valve

2019 ◽  
pp. 85-91
Author(s):  
Hitoshi Yaku ◽  
Kiyoshi Doi ◽  
Sachiko Yamazaki ◽  
Satoshi Numata
Keyword(s):  
Aortic Valve ◽  
Tricuspid Aortic Valve

scholarly journals THE SURGICAL TREATMENT OF AORTIC INSUFFICIENCY BY CONVERSION OF THE TRICUSPID AORTIC VALVE TO A BICUSPID VALVE

1959 ◽  
Vol 37 (2) ◽  
pp. 177-183
Author(s):  
Joseph J. Garamella ◽  
James G. Andersen ◽  
Reuben Oropeza ◽  
Angelo Veloso ◽  
R. Naidu
Keyword(s):  
Surgical Treatment ◽  
Aortic Valve ◽  
Aortic Insufficiency ◽  
Tricuspid Aortic Valve ◽  
Bicuspid Valve

scholarly journals Comparison of bicuspid and tricuspid aortic valve repair

2020 ◽  
Author(s):  
Radosław Gocoł ◽  
Jarosław Bis ◽  
Marcin Malinowski ◽  
Joanna Ciosek ◽  
Damian Hudziak ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Hazard Ratio ◽  
Aortic Valve Repair ◽  
Pericardial Patch ◽  
Valve Regurgitation ◽  
Aortic Valve Regurgitation ◽  
Valve Repair ◽  
Tricuspid Aortic Valve ◽  
Valve Annulus ◽  
Annulus Diameter

Abstract   OBJECTIVES The aim of this study was to compare the outcomes of tricuspid aortic valve (TAV) and bicuspid aortic valve (BAV) repair. METHODS We assessed mortality, freedom from reoperation and the rate of aortic valve regurgitation recurrence. Mortality in both groups was compared with expected survival, and risk factors for reoperation were identified. RESULTS From January 2010 to April 2020, a total of 368 elective aortic valve repair procedures were performed, including 223 (60.6%) in patients with TAV. The perioperative mortality was 0.7% in the BAV group and 3.6% in the TAV group (P = 0.079). Estimated survival at 5 years in the BAV versus TAV group was 97 ± 3% vs 80 ± 6%, respectively (P < 0.001). Freedom from reoperation at 5 years in the TAV versus BAV group was 96 ± 3% vs 93 ± 4%, respectively (P = 0.28). Grade 2 or more aortic valve regurgitation was noted in 9.9% of BAV patients and 11% of TAV patients (P = 0.66). Reoperation was predicted by cusp perforation [hazard ratio 15.86 (4.44–56.61); P < 0.001], the use of pericardial patch [hazard ratio 8.58 (1.96–37.53); P = 0.004] and aortic valve annulus diameter >27.5 mm [hazard ratio 3.07 (0.99–9.58); P = 0.053]. CONCLUSIONS BAV repair is as durable as TAV repair. BAV is not a predictor of a higher rate of reoperations. BAV repair yields survival comparable to expected. Cusp perforation, aortic valve annulus diameter >27.5 mm and the use of pericardial patch adversely impact long-term outcome of aortic valve repair.

Collagen analysis of the ascending aortic dilatation associated with bicuspid aortic valve disease compared with tricuspid aortic valve

2016 ◽  
Vol 122 (5) ◽  
pp. 289-294 ◽  
Author(s):  
Alexander Navarrete Santos ◽  
Junfeng Yan ◽  
Peter Lochmann ◽  
Heike Pfeil ◽  
Michael Petersen ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Bicuspid Aortic Valve ◽  
Aortic Valve Disease ◽  
Valve Disease ◽  
Aortic Dilatation ◽  
Tricuspid Aortic Valve ◽  
Collagen Analysis

A Unique Hybrid Tricuspid Aortic Valve

2021 ◽  
Author(s):  
Jama Jahanyar ◽  
Gaby Aphram ◽  
Laurent de Kerchove ◽  
Gebrine el Khoury
Keyword(s):  
Aortic Valve ◽  
Tricuspid Aortic Valve

scholarly journals Long-term experience with valve-sparing root reimplantation surgery in tricuspid aortic valve

2019 ◽  
Vol 36 (S1) ◽  
pp. 71-80
Author(s):  
Saadallah Tamer ◽  
Stefano Mastrobuoni ◽  
Mona Momeni ◽  
Gaby Aphram ◽  
Emiliano Navarra ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Tricuspid Aortic Valve ◽  
Valve Sparing ◽  
Long Term Experience

scholarly journals A Typical Immune T/B Subset Profile Characterizes Bicuspid Aortic Valve: In an Old Status?

2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Carmela R. Balistreri ◽  
Silvio Buffa ◽  
Alberto Allegra ◽  
Calogera Pisano ◽  
Giovanni Ruvolo ◽  
...  
Keyword(s):  
B Cells ◽  
Aortic Valve ◽  
Aortic Aneurysm ◽  
Thoracic Aortic Aneurysm ◽  
Molecular Mechanisms ◽  
B Lymphocyte ◽  
Valve Disease ◽  
Tricuspid Aortic Valve ◽  
Bicuspid Valve ◽  
Circulating Levels

Bicuspid valve disease is associated with the development of thoracic aortic aneurysm. The molecular mechanisms underlying this association still need to be clarified. Here, we evaluated the circulating levels of T and B lymphocyte subsets associated with the development of vascular diseases in patients with bicuspid aortic valve or tricuspid aortic valve with and without thoracic aortic aneurysm. We unveiled that the circulating levels of the MAIT, CD4+IL−17A+, and NKT T cell subsets were significantly reduced in bicuspid valve disease cases, when compared to tricuspid aortic valve cases in either the presence or the absence of thoracic aortic aneurysm. Among patients with tricuspid aortic valve, these cells were higher in those also affected by thoracic aortic aneurysm. Similar data were obtained by examining CD19+ B cells, naïve B cells (IgD+CD27−), memory unswitched B cells (IgD+CD27+), memory switched B cells (IgD−CD27+), and double-negative B cells (DN) (IgD−CD27−). These cells resulted to be lower in subjects with bicuspid valve disease with respect to patients with tricuspid aortic valve. In whole, our data indicate that patients with bicuspid valve disease show a quantitative reduction of T and B lymphocyte cell subsets. Future studies are encouraged to understand the molecular mechanisms underlying this observation and its pathophysiological significance.

scholarly journals Comparing outcomes after transcatheter aortic valve replacement in patients with stenotic bicuspid and tricuspid aortic valve: A systematic review and meta-analysis

2018 ◽  
Vol 41 (7) ◽  
pp. 896-902 ◽  
Author(s):  
Napatt Kanjanahattakij ◽  
Benjamin Horn ◽  
Wasawat Vutthikraivit ◽  
Sylvia Marie Biso ◽  
Mary Rodriguez Ziccardi ◽  
...  
Keyword(s):  
Systematic Review ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Meta Analysis ◽  
Tricuspid Aortic Valve ◽  
Transcatheter Aortic Valve
Sign in / Sign up

Export Citation Format

Share Document